Chile vs IDA total: Cause of death, by non-communicable diseases, ages 5-14
Chile
59.7%
in 2021
IDA total
21.8%
in 2021
Chile rank
34th
IDA total rank
36th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Chile
- IDA total
How they compare
Chile currently reports 59.7% against 21.8% in IDA total, a difference of 37.9%.
That makes Chile's figure about 2.7 times IDA total's.
Across all 6 years both countries report, Chile has been ahead every year.
Chile ranks 34th and IDA total ranks 36th of 185 countries.
Chile has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | IDA total | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 51.1% | 13.5% | 37.6% | Chile |
| 2010s | 55.4% | 18.3% | 37.1% | Chile |
| 2020s | 59.7% | 21.6% | 38.1% | Chile |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Chile or IDA total?
- Chile, at 59.7% against 21.8% in IDA total as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Chile and IDA total?
- 37.9%, with Chile ahead.
- How many years of comparable data are there for Chile and IDA total?
- 6 years are reported by both, from 2000 to 2021.
- How do Chile and IDA total rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Chile ranks 34th and IDA total ranks 36th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.